AmpliMed amplimed.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels of toxicity. The company is focused on the development of small-molecule oncology drugs with novel mechanisms of action.

AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels of toxicity. The company is focused on the developm...Show all

Company (Alive / Active)

Phone: 520-529-1000

Fax:

4380 North Campbell Avenue
Suite 205
Tucson, 85718
Arizona, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AmpliMed $41.5M Aug 10, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AmpliMed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details

Perpetual Pharmaceuticals

Alive / ActivePerpetual Pharmaceutical is engaged in the development of an insulin-based medication called Briodurance that senses when blood glucose levels are on the riseLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)